![Jennifer Creel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Creel
Nessuna posizione attualmente
Profilo
Jennifer Creel worked as Vice President-Global Finance & Business Planning at Celgene Corp.
from 2008 to 2020.
She then worked as Chief Financial Officer at ADC Therapeutics SA from 2020 to 2022.
Ms. Creel received an undergraduate degree from The College of William & Mary and an MBA from the University of Virginia Darden School of Business.
Precedenti posizioni note di Jennifer Creel
| Società | Posizione | Fine |
|---|---|---|
| ADC THERAPEUTICS SA | Direttore Finanziario/CFO | 19/12/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2020 |
Formazione di Jennifer Creel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
59
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
